Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 3:58 PM UTC
| NCT Number | NCT07499674 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 132 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Vergent Bioscience, Inc. |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT07499674 is currently recruiting participants. This phase3 study for lung cancer is actively seeking new participants at 8 locations across the United States. The study is sponsored by Vergent Bioscience, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07499674 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07499674 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.